BMS 80 855 (Sprycel 80 mg)
Generic Name: dasatinib
Pill with imprint BMS 80 855 is White, Three-sided and has been identified as Sprycel 80 mg. It is supplied by Bristol-Myers Squibb.
Sprycel is used in the treatment of chronic myelogenous leukemia; acute lymphoblastic leukemia; leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Sprycel 80 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BMS 80 855
Sprycel
- Generic Name
- dasatinib
- Imprint
- BMS 80 855
- Strength
- 80 mg
- Color
- White
- Size
- 10.00 mm
- Shape
- Three-sided
- Availability
- Prescription only
- Drug Class
- Bcr-abl tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb
- National Drug Code (NDC)
- 00003-0855
- Inactive Ingredients
-
lactose monohydrate,
microcrystalline cellulose,
croscarmellose sodium,
magnesium stearate,
titanium dioxide
Note: Inactive ingredients may vary.
More about Sprycel (dasatinib)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 17 Reviews
- Generic Availability
- Drug class: BCR-ABL tyrosine kinase inhibitors
- FDA Approval History
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.